Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas

European Radiology

Volumn 20, Issue 10, 2010, Pages 2496-2502

  Plotkin, Michail ^a   Blechschmidt, C ^a   Auf, G ^a   Nyuyki, F ^a   Geworski, L ^b   Denecke, T ^a   Brenner, W ^a   Stockhammer, F ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

2 18F Fluoro 2 deoxy d glucose (FDG); Amino acid PET; Biopsy planning; Glioma; O (2 18F Fluoroethyl) l tyrosine (FET)

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; O (2 FLUOROETHYL) LEVO TYROSINE F 18; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; MALE; MEDICAL HISTORY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR BIOPSY; TUMOR RECURRENCE;

ADULT; AGED; BIOPSY; BRAIN NEOPLASMS; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; GLIOMA; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RECURRENCE; TREATMENT OUTCOME; TYROSINE;

EID: 77957880953     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-010-1819-2     Document Type: Article

References (44)

1. MJ Glantz PC Burger JE Herndon AH Friedman JG Cairncross NA Vick SC Schold Jr 1991 Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas Neurology 41 1741 1744 1:STN:280: DyaK38%2FltVahsQ%3D%3D 1658684
2. JM Brucher 1993 Neuropathological diagnosis with stereotactic biopsies. Possibilities, difficulties and requirements Acta Neurochir 124 37 39 1:STN:280:DyaK2c7gs1ehtQ%3D%3D 10.1007/BF01400714 (Pubitemid 23305969)
3. LM DeAngelis 2001 Brain tumors N Engl J Med 344 114 123 1:STN:280:DC%2BD3M7ksVWjtQ%3D%3D 10.1056/NEJM200101113440207 11150363 (Pubitemid 32052502)
4. M Watanabe R Tanaka N Takeda 1992 Magnetic resonance imaging and histopathology of cerebral gliomas Neuroradiology 34 463 469 1:STN:280:DyaK3s%2FmtlOqtw%3D%3D 10.1007/BF00598951 1436452
5. TN Byrne 1994 Imaging of gliomas Semin Oncol 21 162 171 1:STN:280:DyaK2c3gsVKrsg%3D%3D 8153662
6. LE Ginsberg GN Fuller M Hashmi NE Leeds DF Schomer 1998 The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series Surg Neurol 49 436 440 1:STN:280:DyaK1c7pslSitg%3D%3D 10.1016/S0090-3019(97)00360-1 9537664 (Pubitemid 28153024)
7. D Kondziolka LD Lunsford AJ Martinez 1993 Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma J Neurosurg 79 533 536 1:STN:280:DyaK2c%2FhsFemtw%3D%3D 10.3171/jns.1993.79.4.0533 8410222
8. FG Barker 2nd SM Chang SL Huhn RL Davis PH Gutin MW McDermott CB Wilson MD Prados 1997 Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors Cancer 80 936 941 10.1002/(SICI)1097- 0142(19970901)80:5<936::AID-CNCR15>3.0.CO;2-X 9307194 (Pubitemid 27360923)
9. JN Scott PM Brasher RJ Sevick NB Rewcastle PA Forsyth 2002 How often are nonenhancing supratentorial gliomas malignant? A population study Neurology 59 947 949 1:STN:280:DC%2BD38vovVWlsQ%3D%3D 12297589
10. TL Francavilla RS Miletich G Di Chiro NJ Patronas HV Rizzoli DC Wright 1989 Positron emission tomography in the detection of malignant degeneration of low-grade gliomas Neurosurgery 24 1 5 1:STN:280:DyaL1M7ot1ertg%3D%3D 10.1227/00006123-198901000-00001 2784546
11. S Goldman M Levivier B Pirotte JM Brucher D Wikler P Damhaut E Stanus J Brotchi J Hildebrand 1996 Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy Cancer 78 1098 1106 1:STN:280:DyaK28znsVamug%3D%3D 10.1002/(SICI)1097- 0142(19960901)78:5<1098::AID-CNCR21>3.0.CO;2-X 8780549 (Pubitemid 26284876)
12. K Herholz U Pietrzyk J Voges R Schroder M Halber H Treuer V Sturm WD Heiss 1993 Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study J Neurosurg 79 853 858 1:STN:280:DyaK2c%2FmsF2jsQ%3D%3D 10.3171/jns.1993.79.6.0853 8246053
13. TZ Wong GJ van der Westhuizen RE Coleman 2002 Positron emission tomography imaging of brain tumors Neuroimaging Clin N Am 12 615 626 10.1016/S1052-5149(02)00033-3 12687915 (Pubitemid 36015495)
14. 18F-FDG-PET Eur J Nucl Med Mol Imaging 29 176 182 1:CAS:528:DC%2BD38XnvFSmtg%3D%3D 10.1007/s00259-001-0690- 4 11926379
15. D Delbeke C Meyerowitz RL Lapidus RJ Maciunas MT Jennings PL Moots RM Kessler 1995 Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET Radiology 195 47 52 1:STN:280:DyaK2M7pvFGrsg%3D%3D 7892494
16. AM Spence M Muzi DA Mankoff SF O'Sullivan JM Link TK Lewellen B Lewellen P Pham S Minoshima K Swanson KA Krohn 2004 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter J Nucl Med 45 1653 1659 15471829
17. K Ishizu S Nishizawa Y Yonekura N Sadato Y Magata N Tamaki T Tsuchida H Okazawa S Miyatake M Ishikawa, et al. 1994 Effects of hyperglycemia on FDG uptake in human brain and glioma J Nucl Med 35 1104 1109 1:CAS:528: DyaK2cXlsFags7s%3D 8014665
18. 18F-fluorodeoxyglucose uptake is associated with 1p and 19q loss in WHO grade II gliomas J Neurosurg 106 633 637 1:CAS:528:DC%2BD2sXksFKjtbc%3D 10.3171/jns.2007.106.4.633 17432715
19. M Levivier N Massager D Wikler J Lorenzoni S Ruiz D Devriendt P David F Desmedt S Simon P Van Houtte J Brotchi S Goldman 2004 Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: clinical experience and proposed classification J Nucl Med 45 1146 1154 15235060
20. 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies J Neurosurg 101 476 483 1:CAS:528:DC%2BD2cXnslynsLg%3D 10.3171/jns.2004.101.3.0476 15352606
21. S Goldman M Levivier B Pirotte JM Brucher D Wikler P Damhaut S Dethy J Brotchi J Hildebrand 1997 Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy J Nucl Med 38 1459 1462 1:CAS:528:DyaK2sXmt1Sksro%3D 9293808
22. 11C-methionine for PET-guided stereotactic brain biopsy of gliomas J Nucl Med 45 1293 1298 1:CAS:528:DC%2BD2cXnsFSmur0%3D 15299051
23. D Pauleit F Floeth K Hamacher MJ Riemenschneider G Reifenberger HW Müller K Zilles HH Coenen KJ Langen 2005 O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas Brain 128 678 687 10.1093/brain/awh399 15689365 (Pubitemid 40380202)
24. KJ Langen K Hamacher M Weckesser F Floeth G Stoffels D Bauer HH Coenen D Pauleit 2006 O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications Nucl Med Biol 33 287 294 1:CAS:528:DC%2BD28Xjs1GksLw%3D 10.1016/j.nucmedbio.2006.01.002 16631076
25. W Weber HJ Wester AL Grosu M Herz B Dzewas HJ Feldmann M Molls G Stocklin M Schwaiger 2000 O-(2-[18F] fluoroethyl)-L-tyrosine and L-[methyl-11C] methionine uptake in brain tumours: Initial results of a comparative study Eur J Nucl Med 27 542 549 1:CAS:528:DC%2BD3cXis1Oqtrw%3D 10.1007/s002590050541 10853810
26. D Pauleit G Stoffels A Bachofner FW Floeth M Sabel H Herzog L Tellmann P Jansen G Reifenberger K Hamacher HH Coenen KJ Langen 2009 Comparison of (18)F-FET and (18)F-FDG PET in brain tumors Nucl Med Biol 36 779 787 1:CAS:528:DC%2BD1MXhtVKrsLfJ 10.1016/j.nucmedbio.2009.05.005 19720290
27. H Bjartmarz S Rehncrona 2007 Comparison of accuracy and precision between frame- based and frameless stereotactic navigation for deep brain stimulation electrode implantation Stereotact Funct Neurosurg 85 235 242 10.1159/000103262 17534136 (Pubitemid 47254536)
28. MJ McGirt AT Villavicencio KR Bulsara AH Friedman 2003 MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen Surgical neurology 59 277 281 10.1016/S0090-3019(03) 00048-X 12748009 discussion 281-282 (Pubitemid 36555622)
29. JE Kim DG Kim SH Paek HW Jung 2003 Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatment Acta Neurochir (Wien) 145 547 554 1:STN:280:DC%2BD3sznsVCgtg%3D%3D 10.1007/s00701-003-0048-8 discussion 554-555 (Pubitemid 37093956)
30. A Muacevic E Uhl HJ Steiger HJ Reulen 2000 Accuracy and clinical applicability of a passive marker based frameless neuronavigation system J Clin Neurosci 7 414 418 1:STN:280:DC%2BD3M%2Fot1SmsA%3D%3D 10.1054/jocn.1999.0226 10942662
31. AM Messing-Junger FW Floeth D Pauleit G Reifenberger R Willing J Gärtner HH Coenen KJ Langen 2002 Multimodal target point assessment for stereotactic biopsy in children with diffuse bithalamic astrocytomas Childs Nerv Syst 18 445 449 1:STN:280:DC%2BD38vjsVWnug%3D%3D 10.1007/s00381-002-0644-6 12192504 (Pubitemid 36013690)
32. FW Floeth D Pauleit M Sabel G Stoffels G Reifenberger MJ Riemenschneider P Jansen HH Coenen HJ Steiger KJ Langen 2007 Prognostic value of O-(2-18Ffluoroethyl)-L-tyrosine PET and MRI in low-grade glioma J Nucl Med 48 519 527 1:CAS:528:DC%2BD2sXhtVert7nM 10.2967/jnumed.106.037895 17401087 (Pubitemid 47571405)
33. K Roessler B Gatterbauer A Becherer M Paul K Kletter D Prayer R Hoeftberger J Hainfellner S Asenbaum E Knosp 2007 Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation Minim Invasive Neurosurg 50 273 280 1:STN:280: DC%2BD2sjislWnuw%3D%3D 10.1055/s-2007-991143 18058643
34. B Stöber U Tanase M Herz C Seidl M Schwaiger R Senekowitsch- Schmidtke 2006 Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F] fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells Eur J Nucl Med Mol Imaging 33 932 939 10.1007/s00259-005-0047-5 16604346 (Pubitemid 44127443)
35. F Stockhammer M Plotkin H Amthauer FK van Landeghem C Woiciechowsky 2008 Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomas J Neuro Oncol 88 205 210 1:CAS:528: DC%2BD1cXovV2kurk%3D 10.1007/s11060-008-9551-3
36. T Hara T Kondo T Hara N Kosaka 2003 Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas J Neurosurg 99 474 479 10.3171/jns.2003.99.3.0474 12959432
37. W Chen DH Silverman S Delaloye J Czernin N Kamdar W Pope N Satyamurthy C Schiepers T Cloughesy 2006 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy J Nucl Med 47 904 911 1:CAS:528:DC%2BD28XmtlWmsbY%3D 16741298
38. B Beuthien-Baumann J Bredow W Burchert F Füchtner R Bergmann HD Alheit G Reiss R Hliscs R Steinmeier WG Franke B Johannsen J Kotzerke 2003 3-O-methyl-6-[18F]fluoro-L-DOPA and its evaluation in brain tumour imaging Eur J Nucl Med Mol Imaging 30 1004 1008 1:CAS:528:DC%2BD3sXlvFaqtb8%3D 10.1007/s00259-003-1205-2 12768333 (Pubitemid 37086943)
39. KJ Langen M Jarosch K Hamacher H Mühlensiepen F Weber F Floeth D Pauleit H Herzog HH Coenen 2004 Imaging of gliomas with cis-4-[18F]fluoro-L- proline Nucl Med Biol 31 67 75 1:CAS:528:DC%2BD2cXltFWhtA%3D%3D 10.1016/S0969-8051(03)00121-5 14741571 (Pubitemid 38115126)
40. AH Jacobs A Thomas LW Kracht H Li C Dittmar G Garlip N Galldiks JC Klein J Sobesky R Hilker S Vollmar K Herholz K Wienhard WD Heiss 2005 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors J Nucl Med 46 1948 1958 1:CAS:528:DC%2BD28XivVSktA%3D%3D 16330557
41. PE Valk CA Mathis MD Prados JC Gilbert TF Budinger 1992 Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole J Nucl Med 33 2133 2137 1:STN:280:DyaK3s%2FpsV2isQ%3D%3D 1334136
42. S Hemm V Rigau J Chevalier MC Picot L Bauchet H El Fertit MA Rodriguez L Cif N Vayssière M Zanca P Baldet F Segnarbieux P Coubes 2005 Stereotactic coregistration of 201Tl SPECT and MRI applied to brain tumor biopsies J Nucl Med 46 1151 1157 16000284
43. M del Valle MD Torres M Gómez Rio A Rodríguez Fernández G Sabatel Hernandez S Ortega Lozano C Ramos Font M Bellon Guardia E López Ramírez JM Llamas Elvira 2004 Value of thallium 201-SPECT in typing brain space-occupying lesions Rev Esp Med Nucl 23 330 337 10.1157/13065800 (Pubitemid 40326485)
44. K Källén M Heiling AM Andersson A Brun S Holtås E Ryding I Rosén 1997 Evaluation of malignancy in ring enhancing brain lesions on CT by thallium-201 SPECT J Neurol Neurosurg Psychiatry 63 569 574 10.1136/jnnp.63.5.569 9408094